Opening Keynotes, • 9/22/25 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Next Opening Keynote: The Future of Rare Disease Trials You Might Also Like Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter Case Studies in Rare Disease Commercialization: Lessons Learned Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development
Opening Keynotes, • 9/22/25 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Next Opening Keynote: The Future of Rare Disease Trials You Might Also Like Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter Case Studies in Rare Disease Commercialization: Lessons Learned Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development
